首頁 > 市場調查報告書 > 醫療設備

病患監測呼吸器

市場調查報告書

商品編碼

1965994

呼吸照護設備市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用戶、地區和競爭對手分類，2021-2031年

Respiratory Care Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End User, By Region & Competition, 2021-2031F

出版日期: 2026年01月19日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球呼吸照護設備市場預計將從 2025 年的 189.2 億美元大幅成長至 2031 年的 310.7 億美元，複合年成長率為 8.62%。

此領域涵蓋用於診斷、監測和治療心肺疾病的各種醫療設備，其成長主要受氣喘和慢性阻塞性肺病（COPD）等慢性疾病全球發病率上升的驅動。美國肺臟協會在2024年的報告中強調了環境因素的影響，指出美國約有1.31億人居住在空氣污染嚴重的地區，這種情況會加劇肺部健康問題，並持續增加對補充氧氣和支氣管衛生用品的需求。

市場概覽
預測期	2027-2031
市場規模：2025年	189.2億美元
市場規模：2031年	310.7億美元
複合年成長率：2026-2031年	8.62%
成長最快的細分市場	監控設備
最大的市場	北美洲

儘管有這些正面跡象，但由於購置先進的呼吸器和監測設備成本高昂，市場仍面臨許多障礙。尤其是在開發中國家，醫療體系的財政限制往往阻礙了這些關鍵設備的採購，導致病患獲得必要治療的機會有限。此外，家庭呼吸服務缺乏統一的報銷機制，為醫療服務提供者和患者都帶來了經濟上的不確定性，這可能會減緩價格敏感地區新治療方法的普及。

市場促進因素

全球慢性及傳染性呼吸系統疾病盛行率的激增是呼吸照護設備市場的主要驅動力。由於污染和空氣傳播病原體導致的肺功能損害在全球範圍內不斷加劇，人們對可靠的診斷和治療性介入的需求日益成長，尤其對於需要長期管理的疾病。日益加重的疾病負擔迫使醫療系統增加呼吸道管理和氧氣療法設備的儲備，以應對需要嚴重監護的患者數量不斷增加的情況。世界衛生組織（世衛組織）發布的《2024年全球結核病報告》進一步印證了這項需求，報告估計，2023年全球將有1,080萬人罹患結核病。

同時，對遠端監測和家庭呼吸護理的需求顯著成長，從根本上改變了服務的提供方式。病患和醫療服務提供者正著眼於智慧型便攜設備，以便在傳統醫院環境之外提供持續護理，旨在降低再入院率並提高生活品質。這種向住宅護理的轉變也體現在主要行業參與者的財務表現中。 Fisher & Paykel Healthcare 報告稱，其家庭護理產品系列2024 年的收入成長了 18%，ResMed 也公佈了季度收入成長 9%。這顯示各企業正在持續投資於先進的住宅呼吸照護生態系統。

市場挑戰

全球呼吸照護設備市場成長的主要障礙之一是先進監測和通氣技術的實施成本高昂。這一經濟障礙嚴重限制了必要醫療設備的採購能力，尤其是在醫療基礎設施往往資金不足的開發中國家。因此，無法購買這些關鍵設備限制了患者獲得必要治療的機會，並減緩了價格敏感地區創新治療方案的推廣應用。

此外，呼吸系統疾病帶來的巨大經濟負擔進一步加劇了醫療預算的壓力，並耗盡了昂貴設備升級的投資資源。歐洲呼吸學會的報告顯示，到2024年，歐盟與肺部健康相關的年度社會成本將達到4,220億歐元，這筆巨額財政負擔給醫療服務提供者帶來了不確定性，並使報銷機制複雜化。因此，由於醫療系統難以平衡不斷上漲的疾病管理成本與對先進技術解決方案的需求，關鍵地區的市場擴張往往停滯不前。

市場趨勢

利用人工智慧 (AI) 和機器學習的預測性診斷技術正在呼吸系統領域迅速發展。這一趨勢的驅動力在於對肺部影像和呼吸生物特徵分析自動化技術的大規模資本投入。目前，一些複雜的演算法正在研發中，這些演算法能夠比人工方法更準確地檢測早期惡性腫瘤和肺結核，從而贏得了投資者對其改善臨床療效資金籌措的強烈信心。例如，Qure.ai 在 2024 年 9 月完成了 6,500 萬美元的 D 輪資金籌措，加速了其人工智慧驅動的肺部健康解決方案在美國市場的擴張。這凸顯了業界對自動化診斷能力的重視。

同時，物聯網和智慧連接技術在呼吸設備中的應用正在改變市場格局。這正在建立一個可互通的醫療生態系統，將硬體與臨床監護平台直接連接起來。製造商正逐步將高精度資料傳輸模組整合到患者監護儀和人工呼吸器中，從而實現對呼吸動態的持續遠端監測，顯著改善醫院工作流程並提升病患安全。皇家飛利浦最新的財務數據顯示，其互聯醫療業務板塊2023年的可比收入成長了5%，這主要得益於其醫院病患監測產品組合的兩位數成長，也印證了其對網路解決方案的戰略重點。

The Global Respiratory Care Devices Market is projected to expand significantly, rising from USD 18.92 Billion in 2025 to USD 31.07 Billion by 2031, reflecting a compound annual growth rate of 8.62%. This sector encompasses a wide variety of medical equipment utilized for the diagnosis, monitoring, and treatment of cardiopulmonary disorders, with growth primarily fueled by the increasing global incidence of chronic ailments like asthma and chronic obstructive pulmonary disease. Highlighting the impact of environmental factors, the American Lung Association reported in 2024 that nearly 131 million individuals in the United States resided in areas with hazardous air pollution levels, a condition that worsens lung health and sustains the demand for supplemental oxygen and bronchial hygiene tools.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 18.92 Billion
Market Size 2031	USD 31.07 Billion
CAGR 2026-2031	8.62%
Fastest Growing Segment	Monitoring Devices
Largest Market	North America

Despite these positive indicators, the market faces a substantial obstacle due to the high acquisition costs associated with sophisticated ventilation and monitoring equipment. Financial limitations within healthcare systems, particularly in developing nations, often hinder the procurement of these vital devices, thereby restricting patient access to essential care. Furthermore, inconsistent reimbursement frameworks for home-based respiratory services introduce financial unpredictability for both healthcare providers and patients, which can delay the widespread adoption of newer therapeutic methods in regions that are sensitive to price fluctuations.

Market Driver

The surging global prevalence of chronic and infectious respiratory illnesses acts as the primary force accelerating the respiratory care devices market. As pollution and airborne pathogens increasingly compromise lung function worldwide, the demand for reliable diagnostic and therapeutic interventions has intensified, especially for conditions requiring prolonged management. This growing disease burden necessitates that healthcare systems augment their inventories of airway management and oxygen therapy equipment to accommodate the rising number of patients requiring critical support, a need underscored by the World Health Organization's 'Global Tuberculosis Report 2024', which estimated that 10.8 million people fell ill with tuberculosis globally in 2023.

In parallel, there is a marked increase in the demand for remote monitoring and home-based respiratory care, which is fundamentally transforming service delivery. Patients and medical providers are gravitating towards smart, portable devices that enable continuous therapy outside of conventional hospital environments, aiming to lower readmission rates and improve quality of life. This shift towards residential treatment is reflected in the financial results of key industry players; Fisher & Paykel Healthcare reported an 18% revenue increase in their Homecare product group in 2024, while ResMed saw a 9% rise in quarterly revenue, confirming the continued investment in advanced, home-focused respiratory care ecosystems.

Market Challenge

A major impediment to the growth of the global respiratory care devices market is the steep cost associated with acquiring advanced monitoring and ventilation technologies. This economic barrier significantly curtails the ability to procure necessary medical equipment, particularly in developing countries where healthcare infrastructure is often underfunded. Consequently, the inability to purchase these critical devices restricts patient access to essential treatments and decelerates the wider adoption of innovative therapeutic solutions in regions that are highly sensitive to pricing pressures.

Additionally, the immense economic strain caused by respiratory diseases places further pressure on healthcare budgets, leaving few resources available for investing in expensive equipment upgrades. According to the European Respiratory Society, the annual societal cost of lung health in the European Union hit €422 billion in 2024, a massive financial burden that generates uncertainty for providers and complicates reimbursement structures. As a result, market expansion is often stalled in key territories as healthcare systems struggle to balance the escalating costs of disease management with the necessity for advanced technological solutions.

Market Trends

The application of Artificial Intelligence and Machine Learning for predictive diagnostics is gaining significant traction within the respiratory sector, driven by major capital investments in technologies that automate the analysis of lung imaging and respiratory biometrics. This trend involves the creation of advanced algorithms capable of detecting early-stage malignancies and tuberculosis with greater accuracy than manual methods, thereby attracting strong investor confidence in their potential to improve clinical outcomes. Demonstrating this financial momentum, Qure.ai secured $65 million in Series D funding in September 2024 to expedite the expansion of its AI-driven lung health solutions into the US market, confirming the high industry value placed on automated diagnostic capabilities.

Simultaneously, the integration of IoT and smart connectivity into respiratory devices is transforming the market by establishing interoperable care ecosystems that link hardware directly with clinical oversight platforms. Manufacturers are progressively embedding high-fidelity data transmission modules into patient monitors and ventilators to enable continuous, remote observation of respiratory mechanics, which significantly enhances hospital workflow and patient safety. This strategic emphasis on networked solutions is supported by recent financial data from Royal Philips, which reported a 5% increase in comparable sales for its Connected Care segment in 2023, driven by double-digit growth in its hospital patient monitoring portfolio.

Key Market Players

Dragerwerk AG & Co. KGaA
Fisher & Paykel Healthcare Limited
General Electric Company
Getinge AB
Inogen, Inc.
Masimo
Medtronic
Koninklijke Philips N.V.
ResMed
VYAIRE

Report Scope

In this report, the Global Respiratory Care Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Care Devices Market, By Product

Therapeutic Devices
Monitoring Devices
Consumables
Accessories

Respiratory Care Devices Market, By End User

Hospitals & Clinics
Ambulatory Surgical Centers
Others

Respiratory Care Devices Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Care Devices Market.

Available Customizations:

Global Respiratory Care Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Care Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Therapeutic Devices, Monitoring Devices, Consumables, Accessories)
- 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Respiratory Care Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By End User
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Respiratory Care Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By End User
- 6.3.2. Canada Respiratory Care Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By End User
- 6.3.3. Mexico Respiratory Care Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By End User

7. Europe Respiratory Care Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By End User
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Respiratory Care Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By End User
- 7.3.2. France Respiratory Care Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By End User
- 7.3.3. United Kingdom Respiratory Care Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By End User
- 7.3.4. Italy Respiratory Care Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By End User
- 7.3.5. Spain Respiratory Care Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By End User

8. Asia Pacific Respiratory Care Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By End User
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Respiratory Care Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By End User
- 8.3.2. India Respiratory Care Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By End User
- 8.3.3. Japan Respiratory Care Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By End User
- 8.3.4. South Korea Respiratory Care Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By End User
- 8.3.5. Australia Respiratory Care Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By End User

9. Middle East & Africa Respiratory Care Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By End User
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Respiratory Care Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By End User
- 9.3.2. UAE Respiratory Care Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By End User
- 9.3.3. South Africa Respiratory Care Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By End User

10. South America Respiratory Care Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By End User
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Respiratory Care Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By End User
- 10.3.2. Colombia Respiratory Care Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By End User
- 10.3.3. Argentina Respiratory Care Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Respiratory Care Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Dragerwerk AG & Co. KGaA
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Fisher & Paykel Healthcare Limited
15.3. General Electric Company
15.4. Getinge AB
15.5. Inogen, Inc.
15.6. Masimo
15.7. Medtronic
15.8. Koninklijke Philips N.V.
15.9. ResMed
15.10. VYAIRE